Search

everythinglearnresearchcommunity

for

Search:↓

Confocal Laser Scanning Microscopy (CLSM) is a useful tool for studying how drugs interact with skin and diagnosing skin disorders, despite some limitations.

Satoyoshi syndrome can cause eye problems like uveitis and retinal vein issues.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Chitosan-coated nanocapsules improve minoxidil delivery for better hair regrowth.

Microneedles in wearables can deliver drugs over time but face challenges in manufacturing and safety.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.

Current research on seborrheic dermatitis highlights key focus areas and suggests future study directions.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.

Tacrolimus can cause hair loss in kidney transplant patients.

Scalp condition healed with prednisone and tacrolimus.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Topical tacrolimus reduces certain growth factors in hair follicles.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Switching to generic tacrolimus was safe, effective, and saved money.

Tacrolimus treatment for autoimmune hepatitis can cause hair loss.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.